EMT, CTCs and CSCs in tumor relapse and drug-resistance - Test2 - elhamkhani - TriplyDB

EMT, CTCs and CSCs in tumor relapse and drug-resistance

EMT, CTCs and CSCs in tumor relapse and drug-resistance

http://www.wikidata.org/entity/Q28082935

about

Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance Cancer stem cells (CSCs), cervical CSCs and targeted therapies Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4 Medulloblastoma stem cells: Promising targets in medulloblastoma therapy New Insights into the Crossroads between EMT and Stemness in the Context of Cancer Targeting dormant micrometastases: rationale, evidence to date and clinical implications Cancer Stem Cell Plasticity Drives Therapeutic Resistance Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy The role of EMT and MET in cancer dissemination Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Tumor cell dormancy Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer AKT-ions with a TWIST between EMT and MET Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells SORBS1 suppresses tumor metastasis and improves the sensitivity of cancer to chemotherapy drug Circulating Tumor Cells: From Theory to Nanotechnology-Based Detection.Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cells New insights into the role of EMT in tumor immune escape.OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.Cancer stemness and metastatic potential of the novel tumor cell line K3: an inner mutated cell of bone marrow-derived mesenchymal stem cells.Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress."Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic Characterization of adipose-derived stem cells from subcutaneous and visceral adipose tissues and their function in breast cancer cells Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition.Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention Interleukin-6 suppression reduces tumour self-seeding by circulating tumour cells in a human osteosarcoma nude mouse model GDF15 promotes EMT and metastasis in colorectal cancer.Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells Identification of chromatin accessibility domains in human breast cancer stem cells.Imaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow Spheroids Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.

P2860

Q26740207-03D8BE64-F8F7-4EDA-A23E-BDD54AD6EDEE Q26741223-6F2CAD7A-728A-4735-ABAD-F7A7670C295A Q26746986-85F8E555-F48F-4367-ABFF-D34DBE703674 Q26747144-D3766253-1FDD-45F0-9650-D30CD939DAC8 Q26748850-EF5A7779-C629-4FB6-95B2-E59432529911 Q26749143-495B9A3F-D757-485F-89E8-0E64763210E8 Q26749150-946BF8C9-6B94-423F-A4EA-9E3EED4C2B62 Q26750427-A15B7669-2D52-4D18-B5D1-A22F5EC3FD65 Q26764831-8189EA2E-08AA-4B92-ABD6-9AE63CEB36DD Q26765205-2066C706-661E-43B0-8BEE-F802E271491A Q26770274-007D2715-6F41-46C4-9062-259CE6EAA625 Q26772300-045EFF1D-B713-4250-A954-09C98BA4E76C Q26796298-915EC51A-6FDC-466A-A070-47059D8C4561 Q28067549-544FCF89-4FD7-4D31-AF0A-796AC847AACE Q28073065-3321822C-7E65-415F-BC7D-8BF4628E2F7B Q28073765-70BB40E0-E7E2-434B-9082-9455238C586D Q28078987-33C836B3-AEBB-4C30-8744-8F2FEB7FF92D Q28079205-98F3A166-EEF4-4498-B7CB-4775C98FAED3 Q29048401-9242D6FF-36D8-4087-ADE1-FB7EE0AA462F Q30008832-9B1DACA3-9AB6-4F7F-84B6-4E7738198D5E Q30363234-37317F91-A3B0-4A22-8CCC-981CF513A42B Q33865464-386E9A17-70CC-401C-A93F-D027D79C8727 Q33869781-1DFE95F8-C969-4BF5-BFEA-CD776FC27C78 Q33889211-2386A511-308A-457E-BC33-0108B0AF0B1A Q33889255-AA0C8DC6-44EA-43AD-9FB8-6007009DEEAA Q35943145-4502E604-F17A-4C14-A383-40E0CCA25688 Q36187533-D96DCC6A-07C4-4D90-9F97-E24CD6E6404F Q36322381-553AAB67-A4BA-4446-B611-897B9765D78A Q36416071-3B4D06AA-6DAD-4FC1-94DD-786B613536B2 Q36544129-2A4AC840-157E-4B86-A009-29C8D8CA5952 Q36545991-E17ABF58-2573-498F-AD15-819B06B0EFE3 Q36562108-D7978695-B20C-4CCB-A6F6-592BA8BE9ADF Q36595032-89CA6C78-7C3E-4C51-8EB7-1CBE6D4AF149 Q36638387-7487F045-FB8C-4218-B4DF-C678BB6F6308 Q36729446-43E3B669-5D39-4183-BD80-0F10B840B7F5 Q36729546-5D101DF2-0E30-4327-893F-5D58043F753B Q37020846-D5FDB109-D86E-48AD-8083-E74F956D6D9D Q37028506-AC82B044-8C34-415B-8A4E-B6601078A79C Q37130950-CB15D605-6968-4E98-98C6-4705CC48F680 Q37179512-0D250017-DD3E-45D0-9020-6AF964A3515E

P2860

EMT, CTCs and CSCs in tumor relapse and drug-resistance

http://www.wikidata.org/entity/Q28082935

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@ast

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@en

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@nl

type

label

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@ast

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@en

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@nl

prefLabel

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@ast

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@en

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@nl

P1433

Q28082935-CF7E6E4F-6F19-4D92-BDF4-19C1F1723983

P1476

Q28082935-8C49F98C-1278-4091-A0E4-E12055D65214

P2093

Q28082935-566B3EE4-DB1E-49EE-8A5A-4048581CAEE8

Q28082935-BF5D857B-B9A5-4C5B-8A52-ED1341A59FCD

Q28082935-EB2BAD05-43D3-4792-86F6-6A25FC71BCA9

P275

Q28082935-91384ACF-6D16-4B5D-818A-C8201FCFA03A

P2860

Q28082935-0153BD01-D443-417F-B8DA-F2CDFA5BED12

Q28082935-05059232-EEE4-4071-BADB-B80346268904

Q28082935-058E77B4-B1A6-4FD3-8ED3-3AC37021383D

Q28082935-05CCA6B0-41C1-49D5-B997-43B0CA23241A

Q28082935-06A4C00C-AC8D-4D26-A18C-7D0088725708

Q28082935-09E3A211-CF9B-471A-84BE-6764978E5EA9

Q28082935-09F1928D-E2C8-4FB9-A89E-A49E984C020F

Q28082935-0A31268A-E8E6-4963-B281-E610007245C5

Q28082935-0AF9BC41-78D0-4C57-AD10-A53F1D1263FB

Q28082935-0B9E7ED0-2557-48A9-8747-5EE8E97C187F

P304

Q28082935-C8BCEF93-54BE-4F4B-816C-B447DE4242E5

P31

Q28082935-5D26145C-BA0F-4645-82CE-C395A38031B9

Q28082935-A5C9C69F-EC48-48B0-9817-12B45D0F70A9

P3181

Q28082935-75748942-36D3-4605-8E5C-60E6D758A008

P356

Q28082935-7B2B2E6B-D17C-48DB-A07A-7C46132A06B4

P407

Q28082935-1E4CF36F-023F-4790-88FC-05F207D4FAD2

P433

Q28082935-44CA900C-2BD0-48D3-AF51-B1769FF07357

P478

Q28082935-EC3577FF-EACB-4893-A2FB-178FE089F0FD

P5008

Q28082935-C3DAC159-651D-4F1B-A46B-2424B0A98CFE

P577

Q28082935-18523441-1100-475B-8A42-F8D09918F0F7

P5875

Q28082935-6581D684-671A-44A4-9422-0B531C96674C

P698

Q28082935-47840679-51AD-418C-BEC7-BA96C22426C0

P921

Q28082935-185446E6-AFE3-4791-8D04-2E24777A1D8D

Q28082935-59FB5B93-52BE-43FA-A403-EB6BFD222B5F

Q28082935-791476D1-5858-4E10-A7B6-A1C95E7A4B98

Q28082935-BFEB5053-29CF-4D6D-9E13-EF6DCEEC15DB

P932

Q28082935-6AEF9187-890D-4D5E-ACEB-882272CB330F

P3181

P356

ONCOTARGET.4037

P1433

P1476

EMT, CTCs and CSCs in tumor relapse and drug-resistance

@en

P2093

Abhisek Mitra

http://www.w3.org/2001/XMLSchema#string

Lopa Mishra

http://www.w3.org/2001/XMLSchema#string

Shulin Li

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

The epithelial-mesenchymal transition (EMT) phenomenon

Epithelial-mesenchymal plasticity in carcinoma metastasis

Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research

Mechanisms of disseminated cancer cell dormancy: an awakening field

Identification of selective inhibitors of cancer stem cells by high-throughput screening

IMD-0354 targets breast cancer stem cells: a novel approach for an adjuvant to chemotherapy to prevent multidrug resistance in a murine model

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

Hepatocellular carcinoma

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

Targeting multidrug resistance in cancer

P304

10697-711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

306529

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/ONCOTARGET.4037

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2015-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277087612

http://www.w3.org/2001/XMLSchema#string

P698

25986923

http://www.w3.org/2001/XMLSchema#string

P921

local neoplasm recurrence

physiological phenomena

P932

4484413

http://www.w3.org/2001/XMLSchema#string